Enzymit Partners with Aleph Farms to Market Cultivated Meat
Enzymit announced the development of insulin substituents in partnership with food technology company Aleph Farms that are intended to reduce the cost and development time for producing cultivated meat at scale.
One of the most prohibitive expenses in scaling up cultivated meat production is developing non-animal-derived serum protein mimetics that promote and support cell growth. Such proteins are not widely available in the current market at the quantity, quality and cost necessary for large-scale production. Aleph Farms turned to Enzymit to co-develop novel insulin substituents in microorganisms that can fulfill the function of proteins found naturally in animals with greater desired activity per molecule.